Navigation Links
New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/16/2008

saturation should be greater than or equal to 20% and

ferritin should be greater than or equal to 100 ng/mL. During therapy

absolute or functional iron deficiency may develop and all patients

will eventually require supplemental iron to adequately support

erythropoiesis stimulated by PROCRIT.

-- During PROCRIT therapy, blood pressure should be monitored carefully

and aggressively managed, particularly in patients with an underlying

history of hypertension or cardiovascular disease.

-- In studies, the most common side effects included fever (pyrexia),

diarrhea, nausea, vomiting, swelling of hands or feet (edema), lack or

loss of strength or weakness (asthenia, fatigue), shortness of breath,

high blood pressure, headache, joint pain (arthralgias), abnormal skin

sensations (as tingling or tickling or itching or burning;

paresthesia), rash, constipation and upper respiratory infection.

Please visit http://www.procrit.com for the full Prescribing Information, including the Boxed WARNINGS.

About Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients' health. Located in Bridgewater, N.J., Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit http://www.orthobiotech.com.

Note:
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
3. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
4. Clinical Impact of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
5. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
6. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
7. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
8. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women
9. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
10. Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System
11. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...Newswire-USNewswire/ -- The Florida,Technology, Re...ida,Atlantic University researcher Dr. Herbert Wei...e Center for Molecular Biology and,Biotechnology i...HS,Resources LLC (CHS), $184,294 as part of the St...ce Grant program (SURECAG). SURECAG was,establishe...
(Date:9/5/2008)...ire-FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ... arthritis data,at the Marcus Evans conference on ...y Dr. Daniel Zimmerman, Senior Vice President of R...that CEL-SCI,s rheumatoid,arthritis vaccine CEL-20...,caused by rheumatoid arthritis in an animal model...
(Date:9/5/2008)...RNewswire-USNewswire/ -- A team of,researchers at ...rants from,India and Pakistan take on the habits o... prostate cancer among male immigrants and breast ...e cancer develop due to many reasons, but,environm...hese cancers,",said Jame Abraham, M.D., medical di...
(Date:9/4/2008)... /- Cytopia Limited (ASX:,CYT) today ...Phase Ib/II,study of CYT997, the company,s novel v...ith an aggressive form of brain cancer known as gl...ial is the first Phase II efficacy study in highly... and the second in its,suite of Phase II studies d...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 1EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 3New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 1New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 2New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 3New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 4New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 5Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 1Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 2Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 3Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 4Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 5Par Pharmaceutical Reports First Quarter 2008 Results 18874 1Par Pharmaceutical Reports First Quarter 2008 Results 18874 2Par Pharmaceutical Reports First Quarter 2008 Results 18874 3Par Pharmaceutical Reports First Quarter 2008 Results 18874 4Par Pharmaceutical Reports First Quarter 2008 Results 18874 5Par Pharmaceutical Reports First Quarter 2008 Results 18874 6Par Pharmaceutical Reports First Quarter 2008 Results 18874 7Par Pharmaceutical Reports First Quarter 2008 Results 18874 8Par Pharmaceutical Reports First Quarter 2008 Results 18874 9Par Pharmaceutical Reports First Quarter 2008 Results 18874 10Par Pharmaceutical Reports First Quarter 2008 Results 18874 11Par Pharmaceutical Reports First Quarter 2008 Results 18874 12
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...r Ranbaxy Laboratories Limited Friday announced th...a patients//. "Ranbaxy has introduced this product... in HFA (Hydroxy fluoro Alkane: the propellant) ba... in two strengths - Osonide 160mcg and Osonide 80m...
...ceive themselves as being fat, despite being norma...ping depression and school-related stress//, repor...d be due to an inclination to Western culture and ...ful'. The researchers surveyed more than 7000 mid...
...ventis SA announced on Thursday that the US Food a...g Taxotere to treat patients with stomach cancer./... combination with chemotherapy drugs cisplatin and...s that have not been treated with chemotherapy. T...
...the sex clinic only report of failing to get arous... present with just the opposite complaints//. Cont...ring from the so-called persistent sexual arousal ...ut unprovoked feelings of excitement. Currently, ...
Other Medicine News:Health News:Obese Chinese Teens Low On Self-Esteem 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: